Tools

LEADER 02842cam 2200529 a 4500

001 ocn727303322;

003 OCoLC;

005 20141212070934.0;

008 110524s2011 flua b 001 0 eng ;

010 a| 2011022159;

016 7 a| 1015613432| DNLM;

019 a| 668196908;

020 a| 9781439862216 (hardcover : alk. paper);

020 a| 1439862214 (hardcover : alk. paper);

029 1 a| NLMb| 101561343;

035 a| (Sirsi) o727303322;

035 a| (OCoLC)727303322z| (OCoLC)668196908;

035 a| (OCoLC)727303322;

042 a| pcc;

049 a| NEHH;

050 00 a| RC280.T6b| T534 2011;

060 00 a| 2011 H-129;

060 10 a| WK 270;

082 00 a| 616.99/4442| 23;

245 00 a| Thyroid cancer :b| from emergent biotechnologies to clinical practice guidelines /c| edited by Angelo Carpi, Jeffrey I. Mechanick.;

300 a| xvii, 390 pages :b| illustrations (some color) ;c| 27 cm;

336 a| text2| rdacontent;

337 a| unmediated2| rdamedia;

338 a| volume2| rdacarrier;

504 a| Includes bibliographical references and index.;

520 a| "Thyroid cancer evaluation and treatment has enjoyed very little evolution in comparison with other disease management strategies. The standard treatment algorithms for thyroid cancer have varied only in response to major, though infrequent, biotechnological innovations. These resultant algorithm node insertions produced paradigm changes, but there has been little to advance the care of the patient with advanced thyroid cancer--until very recently. Perhaps the reasons for a relative lack of interest and scientific progress are the overwhelming likelihood of benignity among thyroid nodules, the overwhelmingly favorable clinical outcome even if a patient has thyroid cancer, and the overwhelming long time required for clinical follow-up of these cancer patients. Unfortunately, the problem now is that we may be overmanaging low-risk patients, and we have not achieved the clinical responses we would have liked with high-risk patients"--Provided by publisher.;

650 0 a| Thyroid glandx| Cancer.=| ^A452159;

650 12 a| Thyroid Neoplasmsx| diagnosis.=| ^A924750;

650 12 a| Thyroid Neoplasmsx| therapy.=| ^A927196;

700 1 a| Carpi, A.q| (Angelo)=| ^A1047436;

700 1 a| Mechanick, Jeffrey I.=| ^A947321;

938 a| Baker and Taylorb| BTCPn| BK0009287414;

938 a| YBP Library Servicesb| YANKn| 3564050;

949 a| WK 270 T549 2011h| HSL70i| 31740082712849o| hdjrp| $ 139.95;

994 a| C0b| NEH;

096 a| WK 270 T549 2011;

590 a| Laupus-WCP;

596 a| 4;

998 a| 2537161;

999 a| WK 270 T549 2011w| NLMc| 1i| 31740082712849d| 9/9/2011e| 9/6/2011l| HSLBKm| HSLp| $139.95r| Ys| Yt| HBKu| 9/6/2011x| BOOKz| HSTACKSo| .STAFF. hdjr;

Thyroid cancer : from emergent biotechnologies to clinical practice guidelines / edited by Angelo Carpi, Jeffrey I. Mechanick.

Other author	Carpi, A. (Angelo)
Other author	Mechanick, Jeffrey I.
Format	Book
Publication Info	Boca Raton, FL : CRC Press, ©2011.
Description	xvii, 390 pages : illustrations (some color) ; 27 cm
Subjects	Thyroid gland--Cancer. Thyroid Neoplasms--diagnosis. Thyroid Neoplasms--therapy.

Abstract	"Thyroid cancer evaluation and treatment has enjoyed very little evolution in comparison with other disease management strategies. The standard treatment algorithms for thyroid cancer have varied only in response to major, though infrequent, biotechnological innovations. These resultant algorithm node insertions produced paradigm changes, but there has been little to advance the care of the patient with advanced thyroid cancer--until very recently. Perhaps the reasons for a relative lack of interest and scientific progress are the overwhelming likelihood of benignity among thyroid nodules, the overwhelmingly favorable clinical outcome even if a patient has thyroid cancer, and the overwhelming long time required for clinical follow-up of these cancer patients. Unfortunately, the problem now is that we may be overmanaging low-risk patients, and we have not achieved the clinical responses we would have liked with high-risk patients"--Provided by publisher.
Local note	Laupus-WCP
Bibliography note	Includes bibliographical references and index.
LCCN	2011022159
ISBN	9781439862216 (hardcover : alk. paper)
ISBN	1439862214 (hardcover : alk. paper)

Availability

Library	Location	Call Number	Status	Item Actions
Laupus	Books - Stacks	WK 270 T549 2011	✔ Available	Place Hold

Thyroid cancer : from emergent biotechnologies to clinical practice guidelines / edited by Angelo Carpi, Jeffrey I. Mechanick.

Click here for more information about this title

Availability